Really I think AHZ are on the right path now costs are down and AHZ has the necessary funds to do the initial human trials for the TAVR . Most here doubted the tech and its value but I have never doubted it . WP surprised everyone with the Cardiocel deal even me as it was not the deal I expected . In the process of making this deal I am 100% sure WP has already found at least one prospective partner for the TAVR . Partnering with the TAVR was WP main objective over the last 6 mths , I would suggest the fact no human trials have been done was the main stumbling block . Now AHZ has the funds to complete human trials . If AHZ has successful trials I would not be surprised if WP already has a number of deals on the table . Over the last few weeks I have seen another company I have shares in start to rise from the ashes OSL. , It does happen , I did a similar thing as I did here and bought up big while the SP was tanked out . Let’s hope WP and the board have learnt from previous mistakes. ( not done intentionally ) and AHZ goes on to be the company we all thought it could be . After all the slagging on WP and the board ( some of it deserved ) over the last 12 mths I hope everyone realises they are only human and everyone makes mistakes . WP and the board have done the right thing by all the RI over the last months by putting the companies shares in suspension ( all though some cant see it ) . The SP would have tanked while negotiations were going on and I feel would have led to the company being taken over. ( WP saw that coming ) Hopefully good times lay ahead for AHZ. GLTATH
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-21
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $9.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 475 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 9.800 |
1 | 200 | 9.600 |
1 | 2 | 9.540 |
1 | 330 | 9.510 |
2 | 1185 | 9.500 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 475 | 2 |
9.990 | 99 | 1 |
10.000 | 250 | 1 |
10.500 | 10005 | 2 |
11.000 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online